Management Team
Dr. Francisco Diaz-Mitoma MD, Ph.D. CEO & Founder
- 20 years of clinical vaccine development experience with Merck, GSK and Chiron.
- Entrepreneurial drive and vision and a dynamic and charismatic leader.
Egidio Nascimento , C.A. , Chief Financial Officer
- 17 years of experience in finance
- CFO for Genome Canada & multiple successful start-ups
Adam Buckley, B.Sc., M.B.A. Director of Corporate Development
- Co-founder and first employee
- Shaped VBI’s early success, closing seed financing and strategic partnerships
Dr. David E. Anderson , Ph.D. VP, Immunology and Co-founder
- Extensive training and publication record in many fields of immunology
- Former faculty member of Harvard Medical School
Dr. Andrei Ogrel , Ph.D. Director of Vaccine Development
- Experienced peptide chemist enabled design of VBI’s proprietary immunogens
Lynne Cullen, BScN Director of Clinical Development
- Experienced clinical trials manager for vaccines and infectious disease.
